【乐心医疗:血糖监测产品获美国FDA注册证】乐心医疗公告,公司申请的血糖监测产品医疗器械注册事宜已通过美国FDA审批。该产品为TeleRPM Gen2 Blood Glucose Monitoring System,由血糖仪、血糖试纸组成,用于体外自测,供糖尿病人家庭使用。血糖仪具备4G功能,可上传测量数据至指定服务器,方便用户及医生在数据平台及时查看数据结果。上述产品的实际销售情况取决于未来市场推广效果,公司目前尚无法预测其对公司未来业绩的影响。

金融界
05 Feb
乐心医疗公告,公司申请的血糖监测产品医疗器械注册事宜已通过美国FDA审批。该产品为TeleRPM Gen2 Blood Glucose Monitoring System,由血糖仪、血糖试纸组成,用于体外自测,供糖尿病人家庭使用。血糖仪具备4G功能,可上传测量数据至指定服务器,方便用户及医生在数据平台及时查看数据结果。上述产品的实际销售情况取决于未来市场推广效果,公司目前尚无法预测其对公司未来业绩的影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10